Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janos Kriston-Vizi is active.

Publication


Featured researches published by Janos Kriston-Vizi.


Developmental Cell | 2014

A Two-Tier Golgi-Based Control of Organelle Size Underpins the Functional Plasticity of Endothelial Cells

Francesco Ferraro; Janos Kriston-Vizi; Daniel Metcalf; Belen Martin-Martin; Jamie Freeman; Jemima J. Burden; David Westmoreland; Clare E. F. Dyer; Alex E. Knight; Robin Ketteler; Daniel F. Cutler

Summary Weibel-Palade bodies (WPBs), endothelial-specific secretory granules that are central to primary hemostasis and inflammation, occur in dimensions ranging between 0.5 and 5 μm. How their size is determined and whether it has a functional relevance are at present unknown. Here, we provide evidence for a dual role of the Golgi apparatus in controlling the size of these secretory carriers. At the ministack level, cisternae constrain the size of nanostructures (“quanta”) of von Willebrand factor (vWF), the main WPB cargo. The ribbon architecture of the Golgi then allows copackaging of a variable number of vWF quanta within the continuous lumen of the trans-Golgi network, thereby generating organelles of different sizes. Reducing the WPB size abates endothelial cell hemostatic function by drastically diminishing platelet recruitment, but, strikingly, the inflammatory response (the endothelial capacity to engage leukocytes) is unaltered. Size can thus confer functional plasticity to an organelle by differentially affecting its activities.


Stem cell reports | 2014

Aberrant α-Adrenergic Hypertrophic Response in Cardiomyocytes from Human Induced Pluripotent Cells

Gabor Foldes; Elena Matsa; Janos Kriston-Vizi; Thomas Leja; Stefan Amisten; Ljudmila Kolker; Thusharika Kodagoda; Nazanin F. Dolatshad; Maxime Mioulane; Karine Vauchez; Tamás Arányi; Robin Ketteler; Michael D. Schneider; Chris Denning; Sian E. Harding

Summary Cardiomyocytes from human embryonic stem cells (hESC-CMs) and induced pluripotent stem cells (hiPSC-CMs) represent new models for drug discovery. Although hypertrophy is a high-priority target, we found that hiPSC-CMs were systematically unresponsive to hypertrophic signals such as the α-adrenoceptor (αAR) agonist phenylephrine (PE) compared to hESC-CMs. We investigated signaling at multiple levels to understand the underlying mechanism of this differential responsiveness. The expression of the normal α1AR gene, ADRA1A, was reversibly silenced during differentiation, accompanied by ADRA1B upregulation in either cell type. ADRA1B signaling was intact in hESC-CMs, but not in hiPSC-CMs. We observed an increased tonic activity of inhibitory kinase pathways in hiPSC-CMs, and inhibition of antihypertrophic kinases revealed hypertrophic increases. There is tonic suppression of cell growth in hiPSC-CMs, but not hESC-CMs, limiting their use in investigation of hypertrophic signaling. These data raise questions regarding the hiPSC-CM as a valid model for certain aspects of cardiac disease.


Nature Communications | 2016

Regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis

Blerida Banushi; Federico Forneris; Anna Straatman-Iwanowska; Adam Strange; Anne-Marie Lyne; Clare Rogerson; Jemima J. Burden; Wendy E. Heywood; Joanna Hanley; Ivan Doykov; Kornelis R. Straatman; Holly Smith; Danai Bem; Janos Kriston-Vizi; Gema Ariceta; Maija Risteli; Chunguang Wang; Rosalyn E. Ardill; Marcin Zaniew; Julita Latka-Grot; Simon N. Waddington; Steven J. Howe; Francesco Ferraro; A Gjinovci; Scott Lawrence; Mark Marsh; Mark A. Girolami; Laurent Bozec; Kevin Mills; Paul Gissen

Post-translational modifications are necessary for collagen precursor molecules (procollagens) to acquire final shape and function. However, the mechanism and contribution of collagen modifications that occur outside the endoplasmic reticulum and Golgi are not understood. We discovered that VIPAR, with its partner proteins, regulate sorting of lysyl hydroxylase 3 (LH3, also known as PLOD3) into newly identified post-Golgi collagen IV carriers and that VIPAR-dependent sorting is essential for modification of lysines in multiple collagen types. Identification of structural and functional collagen abnormalities in cells and tissues from patients and murine models of the autosomal recessive multisystem disorder Arthrogryposis, Renal dysfunction and Cholestasis syndrome caused by VIPAR and VPS33B deficiencies confirmed our findings. Thus, regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis and for the development and function of multiple organs and tissues.


Cell Reports | 2016

Sustained E2F-Dependent Transcription Is a Key Mechanism to Prevent Replication-Stress-Induced DNA Damage.

Cosetta Bertoli; Anna E. Herlihy; Betheney R. Pennycook; Janos Kriston-Vizi; Robertus A. M. de Bruin

Summary Recent work established DNA replication stress as a crucial driver of genomic instability and a key event at the onset of cancer. Post-translational modifications play an important role in the cellular response to replication stress by regulating the activity of key components to prevent replication-stress-induced DNA damage. Here, we establish a far greater role for transcriptional control in determining the outcome of replication-stress-induced events than previously suspected. Sustained E2F-dependent transcription is both required and sufficient for many crucial checkpoint functions, including fork stalling, stabilization, and resolution. Importantly, we also find that, in the context of oncogene-induced replication stress, where increased E2F activity is thought to cause replication stress, E2F activity is required to limit levels of DNA damage. These data suggest a model in which cells experiencing oncogene-induced replication stress through deregulation of E2F-dependent transcription become addicted to E2F activity to cope with high levels of replication stress.


Immunology | 2017

Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes.

Rhiannon Kundu; Aikaterini Theodoraki; Carolin T. Haas; Yanjing Zhang; Benjamin M. Chain; Janos Kriston-Vizi; Mahdad Noursadeghi; Bernard Khoo

Vitamin D is widely reported to inhibit innate immune signalling and dendritic cell (DC) maturation as a potential immunoregulatory mechanism. It is not known whether vitamin D has global or gene‐specific effects on transcriptional responses downstream of innate immune stimulation, or whether vitamin D inhibition of innate immune signalling is common to different cells. We confirmed vitamin D inhibition of nuclear factor‐κB (NF‐κB) and p38 mitogen‐activated protein kinase (MAPK) signalling in monocyte‐derived DC (MDDC) stimulated with lipopolysaccharide (LPS). This was associated with global but modest attenuation of LPS‐induced transcriptional changes at genome‐wide level. Surprisingly, vitamin D did not inhibit innate immune NF‐κB activation in monocyte‐derived macrophages. Consistent with our findings in MDDC, ex vivo vitamin D treatment of primary peripheral blood myeloid DC also led to significant inhibition of LPS‐inducible NF‐κB activation. Unexpectedly, in the same samples, vitamin D enhanced activation of both NF‐κB and MAPK signalling in primary peripheral blood monocytes. In a cross‐sectional clinical cohort, we found no relationship between peripheral blood vitamin D levels and LPS‐inducible activation of NF‐κB and MAPK pathways in monocytes of myeloid DC. Remarkably, however, in vivo supplementation of people with vitamin D deficiency in this clinical cohort also enhanced LPS‐inducible MAPK signalling in peripheral blood monocytes. Therefore, we report that vitamin D differentially modulates the molecular response to innate immune stimulation in monocytes, macrophages and dendritic cells. These results are of importance in the design of studies on vitamin D supplementation in infectious and immunological diseases.


Scientific Reports | 2016

Weibel-Palade body size modulates the adhesive activity of its von Willebrand Factor cargo in cultured endothelial cells.

Francesco Ferraro; Mafalda Lopes da Silva; William Grimes; Hwee Kuan Lee; Robin Ketteler; Janos Kriston-Vizi; Daniel F. Cutler

Changes in the size of cellular organelles are often linked to modifications in their function. Endothelial cells store von Willebrand Factor (vWF), a glycoprotein essential to haemostasis in Weibel-Palade bodies (WPBs), cigar-shaped secretory granules that are generated in a wide range of sizes. We recently showed that forcing changes in the size of WPBs modifies the activity of this cargo. We now find that endothelial cells treated with statins produce shorter WPBs and that the vWF they release at exocytosis displays a reduced capability to recruit platelets to the endothelial cell surface. Investigating other functional consequences of size changes of WPBs, we also report that the endothelial surface-associated vWF formed at exocytosis recruits soluble plasma vWF and that this process is reduced by treatments that shorten WPBs, statins included. These results indicate that the post-exocytic adhesive activity of vWF towards platelets and plasma vWF at the endothelial surface reflects the size of their storage organelle. Our findings therefore show that changes in WPB size, by influencing the adhesive activity of its vWF cargo, may represent a novel mode of regulation of platelet aggregation at the vascular wall.


BMC Biochemistry | 2014

Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs

Christin Luft; Jamie Freeman; David Elliott; Nadia Al-Tamimi; Janos Kriston-Vizi; Jacob Heintze; Ida Lindenschmidt; Brian Seed; Robin Ketteler

BackgroundSecreted luciferases are highly useful bioluminescent reporters for cell-based assays and drug discovery. A variety of secreted luciferases from marine organisms have been described that harbor an N-terminal signal peptide for release along the classical secretory pathway. Here, we have characterized the secretion of Gaussia luciferase in more detail.ResultsWe describe three basic mechanisms by which GLUC can be released from cells: first, classical secretion by virtue of the N-terminal signal peptide; second, internal signal peptide-mediated secretion and third, non-conventional secretion in the absence of an N-terminal signal peptide. Non-conventional release of dNGLUC is not stress-induced, does not require autophagy and can be enhanced by growth factor stimulation. Furthermore, we have identified the golgi-associated, gamma adaptin ear containing, ARF binding protein 1 (GGA1) as a suppressor of release of dNGLUC.ConclusionsDue to its secretion via multiple secretion pathways GLUC can find multiple applications as a research tool to study classical and non-conventional secretion. As GLUC can also be released from a reporter construct by internal signal peptide-mediated secretion it can be incorporated in a novel bicistronic secretion system.


BMC Bioinformatics | 2011

Gebiss: an ImageJ plugin for the specification of ground truth and the performance evaluation of 3D segmentation algorithms

Janos Kriston-Vizi; Ng Wee Thong; Cheok Leong Poh; Kwo Chia Yee; Joan Sim Poh Ling; Rachel Kraut; Martin Wasser

BackgroundImage segmentation is a crucial step in quantitative microscopy that helps to define regions of tissues, cells or subcellular compartments. Depending on the degree of user interactions, segmentation methods can be divided into manual, automated or semi-automated approaches. 3D image stacks usually require automated methods due to their large number of optical sections. However, certain applications benefit from manual or semi-automated approaches. Scenarios include the quantification of 3D images with poor signal-to-noise ratios or the generation of so-called ground truth segmentations that are used to evaluate the accuracy of automated segmentation methods.ResultsWe have developed Gebiss; an ImageJ plugin for the interactive segmentation, visualisation and quantification of 3D microscopic image stacks. We integrated a variety of existing plugins for threshold-based segmentation and volume visualisation.ConclusionsWe demonstrate the application of Gebiss to the segmentation of nuclei in live Drosophila embryos and the quantification of neurodegeneration in Drosophila larval brains. Gebiss was developed as a cross-platform ImageJ plugin and is freely available on the web at http://imaging.bii.a-star.edu.sg/projects/gebiss/.


Biochemistry | 2016

Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members

Krisna Prak; Janos Kriston-Vizi; A. W. Edith Chan; Christin Luft; Joana R. Costa; Niccolo Pengo; Robin Ketteler

Protein kinases are essential regulators of most cellular processes and are involved in the etiology and progression of multiple diseases. The cdc2-like kinases (CLKs) have been linked to various neurodegenerative disorders, metabolic regulation, and virus infection, and the kinases have been recognized as potential drug targets. Here, we have developed a screening workflow for the identification of potent CLK2 inhibitors and identified compounds with a novel chemical scaffold structure, the benzobisthiazoles, that has not been previously reported for kinase inhibitors. We propose models for binding of these compounds to CLK family proteins and key residues in CLK2 that are important for the compound interactions and the kinase activity. We identified structural elements within the benzobisthiazole that determine CLK2 and CLK3 inhibition, thus providing a rationale for selectivity assays. In summary, our results will inform structure-based design of CLK family inhibitors based on the novel benzobisthiazole scaffold.


Cancer Cell | 2018

Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor

Dan Frampton; Hagen Schwenzer; G. Marino; Lee M. Butcher; Gabriele Pollara; Janos Kriston-Vizi; Cristina Venturini; Rachel Austin; Karina Ferreira de Castro; Robin Ketteler; Benjamin M. Chain; Richard A. Goldstein; Robin A. Weiss; Stephan Beck; Ariberto Fassati

Summary The canine transmissible venereal tumor (CTVT) is a clonally transmissible cancer that regresses spontaneously or after treatment with vincristine, but we know little about the regression mechanisms. We performed global transcriptional, methylation, and functional pathway analyses on serial biopsies of vincristine-treated CTVTs and found that regression occurs in sequential steps; activation of the innate immune system and host epithelial tissue remodeling followed by immune infiltration of the tumor, arrest in the cell cycle, and repair of tissue damage. We identified CCL5 as a possible driver of CTVT regression. Changes in gene expression are associated with methylation changes at specific intragenic sites. Our results underscore the critical role of host innate immunity in triggering cancer regression.

Collaboration


Dive into the Janos Kriston-Vizi's collaboration.

Top Co-Authors

Avatar

Robin Ketteler

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gabor Foldes

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Sian E. Harding

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Chris Denning

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

Christin Luft

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jamie Freeman

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maxime Mioulane

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge